PALMITIC MONOISOPROPANOLAMIDE, (R)-

CCCCCCCCCCCCCCCC(=O)NC[C@@H](C)O

InChIKey=VQNMGLLFMPXVFN-GOSISDBHSA-N

InChI=1S/C19H39NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19(22)20-17-18(2)21/h18,21H,3-17H2,1-2H3,(H,20,22)/t18-/m1/s1

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Targets

Primary Target	Pharmacology	Condition	Potency
Cannabinoid CB1 receptor 85 Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11498512	Binding Agent 1076
Cannabinoid CB2 receptor 71 Target ID: CHEMBL253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11498512	Binding Agent 1076

PubMed

Title	Date	PubMed
Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.	2001-08	11498512

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:31:57 GMT 2025` Edited by `admin` on `Mon Mar 31 21:31:57 GMT 2025`
Record UNII	3438DY3589
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

HEXADECANAMIDE, N-((2R)-2-HYDROXYPROPYL)-

Preferred Name

English

PALMITIC MONOISOPROPANOLAMIDE, (R)-

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID30170886

Created by admin on Mon Mar 31 21:31:57 GMT 2025 , Edited by admin on Mon Mar 31 21:31:57 GMT 2025

PRIMARY

PUBCHEM

18395309

Created by admin on Mon Mar 31 21:31:57 GMT 2025 , Edited by admin on Mon Mar 31 21:31:57 GMT 2025

PRIMARY

CAS

179951-56-5

Created by admin on Mon Mar 31 21:31:57 GMT 2025 , Edited by admin on Mon Mar 31 21:31:57 GMT 2025

PRIMARY

FDA UNII

3438DY3589

Created by admin on Mon Mar 31 21:31:57 GMT 2025 , Edited by admin on Mon Mar 31 21:31:57 GMT 2025

PRIMARY